LMR Partners
WGS icon

LMR Partners’s GeneDx Holdings WGS Stock Holding History

LMR Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-279
Closed -$17.9K – 1809
2026
Q1 		$17.9K Buy
+279
New +$25.4K ﹤0.01% 1352
2024
Q2 		– Sell
-2,675
Closed -$24.4K – 1333
2024
Q1 		$24.4K Buy
+2,675
New +$16.1K ﹤0.01% 1023
2022
Q1 		– Sell
-2,575
Closed -$379K – 1360
2021
Q4 		$379K Buy
+2,575
New +$575K ﹤0.01% 975

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

LMR Partners's WGS Position: Q2 2026 in Review

LMR Partners sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 279 shares — an estimated $17.9K sold.

LMR Partners first reported a position in WGS in Q4 2021 and held it in 3 quarters. The position peaked at $379K in Q4 2021. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • LMR Partners reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • LMR Partners sold 279 GeneDx Holdings shares in Q2 2026, an estimated $17.9K.
  • LMR Partners first reported a position in GeneDx Holdings in Q4 2021 and held it in 3 quarters.
  • LMR Partners's GeneDx Holdings position peaked at $379K in Q4 2021.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.